Pernix Therapeutics Holdings Stock Price and Value Analysis

Should you buy Pernix Therapeutics Holdings stock? (NasdaqGM:PTX). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This stock looks overpriced.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the PTX Numbers

PTX Price
(Pernix Therapeutics Holdings stock price per share)
$2.55
[?] PE Ratio versus Sector 83% higher than other Healthcare stocks
[?] PE Ratio versus Industry 28% higher than other Drug Manufacturers - Other stocks
[?] Cash Yield -16.89%
[?] Free Cash Flow Jitter 1089%

Is Pernix Therapeutics Holdings Stock on Sale?

Based on our analysis, we believe that you should not buy Pernix Therapeutics Holdings right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy PTX Stock?

Does Pernix Therapeutics Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.